Bromotyrosine derivatives from marine sponges inhibit the HIV-1 replication in vitro;Bromotirosinas derivadas de esponjas marinas inhiben la replicación in vitro del VIH-1

Vitae

Volumn 21, Issue 2, 2014, Pages 114-125

  Gómez Archila, León G ^a   Zapata, Wildeman ^a,b   Galeano, Elkin ^a   Martínez, Alejandro ^a   Díaz, Francisco J ^a   Rugeles, María T ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD COOPERATIVA DE COLOMBIA   (Colombia)

Author keywords

Antiviral activity; Bromotyrosine; HIV 1; Marine resources; Marine sponge

Indexed keywords

19 DEOXYFISTULARIN; 3 BROMO 5 HYDROXY O METHYL TYROSINE; 3 BROMO N N N TRIMETHYLTYROSINIUM; 3,5 DIBROMO N N N O TETRAMETHYLTYRAMINIUM; 3,5 DIBROMO N N N TRIMETHYLTYRAMINIUM; 3,5 DIBROMO N N N TRIMETHYLTYROSINIUM; AEROPLYSININ 1; BROMOTYROSINE DERIVATIVE; DIHYDROXYAEROTHIONIN; FISTULARIN 3; PUREALIDIN B; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; ZIDOVUDINE;

AIOLOCHORIA CRASSA; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MTT ASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; SPONGE (PORIFERA); VERONGULA RIGIDA; VIRUS REPLICATION;

EID: 84905048823     PISSN: 01214004     EISSN: 21452660     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic 2012. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data; 2012 Nov 20. 110 p.
2. Lehrman G, Hogue I, Palmer S, Jennings C, Spina C, Wiegand A, et al. Depletion of latent HIV-1 infection in vivo: a proof-ofconcept study. The Lancet. 2005; 366 (9485): 549-555.
3. Stekler J, Maenza J, Stevens C, Holte S, Malhotra U, McElrath MJ, et al. Abacavir hypersensitivity reaction in primary HIV infection. Aids. 2006; 20: 1269-1274.
4. Sundaram M, Saghayam S, Priya B, Venkatesh KK, Balakrishnan P, Shankar EM, et al. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. Int J Infect Dis. 2008; 12: 61-66.
5. Kolber MA, Saenz MO, Tanner TJ, Arheart KL, Pahwa S, Liu H. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation. Clin Immunol. 2008; 126: 315-321.
6. Ford PW, Gustafson KR, McKee TC, Shigematsu N, Maurizi LK, Pannell LK, et al. Papuamides A-D, HIV-inhibitory and cytotoxic depsipeptides form the sponges Theonella mirabilis and Theonella swinhoei collected in Papua New Guinea. J Am Chem Soc. 1999; 121: 5899-5909.
7. Qureshi A, Faulkner DJ. Haplosamates A and B: new steroidal sulfamate esters from two haploclerid sponges. Tetrahedron. 1999; 55: 8323-8330.
8. Chang L, Whittaker NF, Bewley CA. Crambesidin 826 and dehyrocrambine A: a new polycyclic guanidine alkaloids from the marine sponge Monanchora sp. That inhibit HIV-1 fusion. J Nat Prod. 2003; 66: 1490-1494.
9. Zampella A, Sepe V, Luciano P, Bellotta F, Monti MC, D'Auria MV, et al. Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp. J Org Chem. 2008; 73: 5319-27.
10. Chill L, Rudi A, Aknin M, Loya S, Hizi A, Kashman Y. New sesterterpenes from Madagascan Lendenfeldia sponges. Tetrahedron. 2004; 60: 10619-10626.
11. Oku N, Gustafson KR, Cartner LK, Wilson JA, Shigematsu N, Hess S, et al. Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi. J Nat Prod. 2004; 67: 1407-1411.
12. Goud TV, Reddy NS, Swamy NR, Ram TS, Venkateswarlu Y. Anti-HIV active petrosins from the marine sponge Petrosia similes. Biol Pharm Bull. 2003; 51: 990-993.
13. Plaza A, Bifulco G, Masullo M, Lloyd JR, Keffer JL, Colin PL, et al. Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Thennella species. J Org Chem. 2010; 75: 4344-55.
14. Plaza A, Bifulco G, Keffer JL, Lloyd JR, Baker HL, Bewley CA. Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. J Org Chem. 2009; 74: 504-12.
15. Lu Z, Van Wagoner RM, Harper MK, Baker HL, Hooper JNA, Bewley CA, et al. Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa. J Nat Prod. 2011; 74: 185-93.
16. Fan G, Li Z, Shen S, Zeng Y, Yang Y, Xu M, et al. Baculiferins A-O, O-sulfated pyrrole alkaloids with anti-HIV-1 activity, from the Chinese marine sponge Iotrochota baculifera. Bioorganic & Medicinal Chemistry. 2010; 18 (15): 5466-5474.
17. Compagnone R, Avila R, Suarez A, Abrams O, Rangel H, Arvelo F, et al. 11-Deoxyfistularin-3, a New Cytotoxic Metabolite from the Caribbean Sponge Aplysina fistularis insularis. J Nat Prod. 1999; 62: 1443-1444.
18. Fattorusso E, Minale L, Sodano G. Aeroplysinin-1, an antibacterial bromo-compound from the sponge Verongia aerophoba. J Chem Soc. 1972; 1: 16-18.
19. Rodríguez-Nieto S, González-Iriarte M, Carmona R, MuñozChápuli R, Medina M, Quesada A. Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J. 2002; 16 (2): 261-263.
20. Galeano E, Thomas OP, Robledo S, Munoz D, Martinez A. Antiparasitic Bromotyrosine Derivatives from the Marine Sponge Verongula rigida. Mar Drugs. 2011; 9: 1902-1913.
21. Galeano E, Thomas OP, Robledo S, Munoz D, Martinez A. Antiparasitic Bromotyrosine Derivatives from the Caribbean Marine Sponge Aiolochroia crassa. Quimica nova. 2012; 35: 1189-1193
22. Schoenfeld R, Lumb J, Fantin J, Ganem B. Total synthesis of mololipids: A new series of anti-HIV Moloka'iamine derivatives. Bioorganic & Medicinal Chemistry Letters. 2000 4; 10 (23): 2679-2681.
23. Ross SA, Weete JD, Schinazi RF, Wirtz SS, Tharnish P, Scheuer PJ, et al. Mololipids, a new series of anti-HIV bromotyraminederived compounds from a sponge of the Order Verongida. J Nat Prod. 2000; 63: 501-503.
24. Harrington RD, Geballe AP. Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol. 1993; 67 (10): 5939-5947.
25. Vodicka MA, Goh WC, Wu LI, Rogel ME, Bartz SR, Scheweickart VL, et al. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology. 1997; 233 (1): 193-198.
26. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol. 2004; 78 (8): 4120-4133.
27. Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: optimization of critical parameters affecting calciumphosphate precipitate formation. Nucleic Acids Res. 1996; 24 (4): 596-601.
28. Vetter ML, D'Aquila RT. Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells. J Virol. 2009; 83(17): 8646-8654.
29. Skern R, Frost P, Nilsen F. Relative transcript quantification by quantitative PCR: roughly right or precisely wrong?. BMC Mol Biol. 2005; 6(1): 10.
30. Muller WEG, Sobel C, Diehl-Seifert B, Maidhof A, Schroder HC. Inf luence of the antileukemic and anti-human immunodeficiency virus agent avarol on selected immune responses in vitro and in vivo. Biochem Pharmacol. 1987; 36: 1489-1494.
31. Muller WEG, Maidhof A, Zahn RK, Schroder HC, Gasic MJ, Heidemann D, et al. Inf luence of the antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivo. Cancer Res. 1985; 45: 4822-826.
32. Loya S, Rudi A, Kashman Y, Hizi A. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA-and DNA-directed DNA polymerases. Biochem J. 2002; 362: 685-692.
33. Loya S, Hizi A. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses. J Biol Chem. 1993; 268: 9323-9328.
34. Rudi A, Yosief T, Loya S, Hizi A, Schleyer M, Kashman Y. Clathsterol, a novel anti-HIV-1 RT sulfated sterol from the sponge Clathria species. J Nat Prod. 2001; 64: 1451-1453.
35. O'Keefe BR, Erim T, Beutler JA, Cardellina II JH, Gulakowski RJ, Krepps BL, et al. Isolation and characterization of adociavirin, a novel HIV-inhibitory protein from the sponge Adocia sp. FEBS Letters. 1998 Jul 10; 431 (1): 85-90.
36. Arts EJ, Hazuda DJ. HIV-1 Antiretroviral Drug Therapy. Cold Spring Harb Perspect Med. 2012; 2 (4): a007161.
37. Ana SE, Marisa N, Madalena H, Joao G. Sulfated Polysaccharides in Marine Sponges: Extraction Methods and Anti-HIV Activity. Mar Drugs. 2011; 9(1): 139-153.